Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: A pilot randomised controlled trial
This pilot randomized controlled trial found no significant difference in menstrual cycle characteristics or endometrial histology between women treated with micronized vaginal progesterone or oral dydrogesterone for irregular dysfunctional uterine bleeding.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (35)
- A new clinical option for hormone replacement therapy in women with secondary amenorrhea: Effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding via openalex
- Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles via openalex
- Medical management of dysfunctional uterine bleeding via openalex
- Use of Crinone∗ vaginal progesterone gel for luteal support in in vitro fertilization cycles via openalex
- doi:10.1093/humrep/15.suppl_1.166 via openalex
- doi:10.1016/j.fertnstert.2004.11.054 via openalex
- doi:10.1016/s0002-9378(97)70297-7 via openalex
- doi:10.1016/s0301-2115(03)00156-8 via openalex
- doi:10.1016/s1472-6483(10)61847-0 via openalex
- doi:10.1007/bf03348808 via openalex
- doi:10.1016/s0029-7844(98)00525-0 via openalex
- doi:10.1016/s0301-2115(02)00004-0 via openalex
- doi:10.1196/annals.1335.022 via openalex
- doi:10.1067/mob.2002.124941 via openalex
- doi:10.1016/s1472-6483(10)60782-1 via openalex
- doi:10.1016/j.fertnstert.2004.01.025 via openalex
- doi:10.1016/s0015-0282(01)02872-2 via openalex
- doi:10.1111/j.1479-828x.1990.tb02028.x via openalex
- doi:10.1016/s0015-0282(99)00364-7 via openalex
- doi:10.1016/s0015-0282(00)01497-7 via openalex
- doi:10.1016/j.fertnstert.2007.03.006 via openalex
- doi:10.1093/humrep/15.6.1284 via openalex
- doi:10.1093/humrep/15.suppl_1.149 via openalex
- doi:10.1016/0378-5122(94)90016-7 via openalex
- W6833243503 via openalex
- doi:10.1093/oxfordjournals.humrep.a019054 via openalex
- doi:10.1201/b13413-12 via openalex
- doi:10.1097/00006250-199904000-00016 via openalex
- doi:10.1093/oxfordjournals.humrep.a136371 via openalex
- doi:10.1016/j.fertnstert.2004.11.073 via openalex
- doi:10.1016/s0301-2115(02)00010-6 via openalex
- doi:10.1016/s0039-128x(00)00123-9 via openalex
- doi:10.1016/s0015-0282(16)56935-0 via openalex
- doi:10.1016/s0015-0282(16)54680-9 via openalex
- doi:10.1016/j.fertnstert.2006.05.067 via openalex
Cited by (6)
- Menorrhagia and the Menopausal Transition 2024
- Progestin Selectivity in Clinical Applications 2024
- The effect of dydrogesterone on sexual function in endometriosis 2021
- Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients 2020
- Abnormal Uterine Bleeding 2017
- Pharmacological therapy for abnormal uterine bleeding 2011
Source provenance
- openalex
- last seen: 2026-05-11T06:00:05.006021+00:00